P15692 (VEGFA_HUMAN) Homo sapiens (Human)

Vascular endothelial growth factor A, long form UniProtKBInterProInteractive Modelling

395 aa; Sequence (Fasta) ; (Isoform 1; Isoform 2; Isoform 3; Isoform 4; Isoform 5; Isoform 6; Isoform 8; Isoform 9; Isoform 10; Isoform 11; Isoform 12; Isoform 14; Isoform 15; Isoform 16; Isoform 17; Isoform 18)

Available Structures

53 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Dual-acting Fab 5A12 in complex with VEGF
4zff
 Heteromer
217-315
1×SO4;
Assess
D-Protein RFX-V2 Bound to the VEGFR1 Domain 3 Site on VEGF-A
7ll9
 Heteromer
217-315
Assess
Solution Structure of a Phage-Derived Peptide Antagonist in Complex with Vascular Endothelial Growt…
1kat
 Heteromer
217-315
Assess
VEGF IN COMPLEX WITH DOMAIN 2 OF THE FLT-1 RECEPTOR
1flt
 Heteromer
P17948; 		218-315
Assess
Crystal structure of hVEGF in complex with VK domain antibody
5fv1
 Heteromer
219-316
Assess
Structure of the B20-4 Fab, a phage derived Fab fragment, in complex with VEGF
2fjh
 Heteromer
218-315
Assess
Crystal structure of an engineered lipocalin (Anticalin) in complex with VEGF(8-109)
4qaf
 Heteromer
P31025; 		218-314
2×OMA; 3×SO4; 1×ACT;
Assess
D-Protein RFX-V1 Bound to the VEGFR1 Domain 2 Site on VEGF-A
7ll8
 Heteromer
219-315
Assess
Crystal Structure of the Fab YADS2 Complexed with h-VEGF
1tzi
 Heteromer
219-315
Assess
Crystal structure of hVEGF in complex with VH domain antibody
5fv2
 Heteromer
218-314
Assess
Structure of VEGF complexed to a Fab containing TYR and SER in the CDRs
2qr0
 Heteromer
219-315
Assess
COMPLEX BETWEEN VEGF AND A RECEPTOR BLOCKING PEPTIDE
1vpp
 Heteromer
219-314
Assess
Crystal structure of an engineered human autonomous VH Domain in complex with VEGF
3p9w
 Heteromer
218-313
Assess
The Development of Peptide-based Tools for the Analysis of Angiogenesis
3s1b
 Heteromer
218-313
Assess
Crystal structure of a bispecific DutaFab in complex with human VEGF121
6t9d
 Heteromer
218-313
Assess
Crystal structure of VEGF-A in complex with VEGFR-1 domains D1-6
5t89
 Heteromer
P17948; 		219-314
2×NAG; 19×NAG;
Assess
Crystal Structure of Chemically Synthesized Heterochiral {D-Protein Antagonist plus VEGF-A} Protein…
4gln
 Heteromer
219-313
Assess
Crystal Structure of Chemically Synthesized Heterochiral {D-Protein Antagonist plus VEGF-A} Protein…
4gls
 Heteromer
219-313
1×PEG; 1×GOL;
Assess
Crystal Structure of Chemically Synthesized Heterochiral {RFX037 plus VEGF-A} Protein Complex in sp…
5hhc
 Heteromer
219-313
2×GOL;
Assess
Crystal Structure of Chemically Synthesized Heterochiral {RFX037 plus VEGF-A} Protein Complex in sp…
5hhd
 Heteromer
219-313
3×GOL;
Assess
Crystal structure of VEGF in complex with heterodimeric Fcab JanusCT6
5o4e
 Heteromer
P0DOX5; 		219-313
2×NAG; 1×MAN; 1×NAG; 10×MPD; 1×MRD; 2×CAC; 1×TRS;
Assess
Crystal structure of bH1 Fab variant (CDR H3 loop design 13_0346) in complex with VEGF
7kf0
 Heteromer
219-313
2×EDO; 1×CL;
Assess
Crystal structure of bH1 Fab variant (CDR H3 loop design 14_0130) in complex with VEGF
7kf1
 Heteromer
219-313
8×CL;
Assess
Structure of Bevacizumab Fab mutant in complex with VEGF
6bft
 Heteromer
P0DOX5; Q8TCD0; 		219-313
2×SO4; 2×MES;
Assess
The Development of Peptide-based Tools for the Analysis of Angiogenesis
3s1k
 Heteromer
219-313
Assess
VASCULAR ENDOTHELIAL GROWTH FACTOR IN COMPLEX WITH DOMAIN 2 OF THE FLT-1 RECEPTOR
1qty
 Heteromer
P17948; 		219-313
Assess
Structure of the G6 Fab, a phage derived Fab fragment, in complex with VEGF
2fjg
 Heteromer
220-314
7×SO4;
Assess
Vascular endothelial growth factor in complex with alpha/beta-VEGF-1
4wpb
 Heteromer
219-313
Assess
VEGFR-2/VEGF-A COMPLEX STRUCTURE
3v2a
 Heteromer
P35968; 		219-313
Assess
Crystal structure of bH1 Fab variant (CDR H3 loop design 16_0325) in complex with VEGF
7kez
 Heteromer
219-312
2×CL;
Assess
VASCULAR ENDOTHELIAL GROWTH FACTOR IN COMPLEX WITH AN AFFINITY MATURED ANTIBODY
1cz8
 Heteromer
220-313
2×SO4;
Assess
VASCULAR ENDOTHELIAL GROWTH FACTOR IN COMPLEX WITH A NEUTRALIZING ANTIBODY
1bj1
 Heteromer
220-313
2×SO4;
Assess
Crystal Structure of the Fab YADS1 Complexed with h-VEGF
1tzh
 Heteromer
220-313
Assess
Human NRP2 b1 domain in complex with the peptide corresponding to the C-terminus of VEGF-A
5dn2
 Heteromer
O60462; 		392-395
Assess
The crystal structure of chemically synthesized VEGF-A
3qtk
homo-2-mer219-315
2×ACT; 4×TFA; 2×GOL;
Assess
Crystal Structure of Vascular Endothelial Growth Factor (VEGF8-109) with HH4, an alpha/beta-Peptide…
6d3o
homo-2-mer219-314
Assess
High resolution structure of VEGF-A 12:107 crystallized in tetragonal form
6zfl
homo-2-mer219-313
4×MPD; 3×PO4;
Assess
VEGF-A 13:107 crystallized with 4C bicyclic peptide
6zbr
homo-2-mer219-313
5×MPD; 1×PO4;
Assess
crystal structure of human VEGF-A receptor binding domain
4kzn
homo-2-mer219-313
2×NAG; 2×PGE; 2×SO4;
Assess
VEGF-A 13:107 crystallized with 1C bicyclic peptide
6zcd
homo-2-mer219-313
5×MPD; 1×PO4;
Assess
VEGF-A 13:107 crystallized with 3C bicyclic peptide
6z13
homo-2-mer219-313
1×NH2; 5×ACY; 2×MPD;
Assess
VASCULAR ENDOTHELIAL GROWTH FACTOR REFINED TO 1.93 ANGSTROMS RESOLUTION
2vpf
homo-2-mer219-313
Assess
DISULFIDE DEFICIENT MUTANT OF VASCULAR ENDOTHELIAL GROWTH FACTOR A (C51A and C60A)
1mjv
homo-2-mer220-314
Assess
VEGF-A 13:107 crystallized with 2C bicyclic peptide
6z3f
homo-2-mer219-313
1×NH2; 1×MPD; 5×ACY;
Assess
Crystal Structure of Vascular Endothelial Growth Factor (VEGF8-109) with one copy of HH4, an alpha/…
6v7k
homo-2-mer219-313
Assess
Dual specific bH1 Fab in complex with VEGF
3bdy
homo-2-mer220-314
Assess
STRUCTURE OF HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR
1vpf
homo-2-mer220-313
Assess
DISULFIDE DEFICIENT MUTANT OF VASCULAR ENDOTHELIAL GROWTH FACTOR A (C57A and C102A)
1mkg
homo-2-mer220-313
Assess
Disulfide deficient mutant of vascular endothelial growth factor A (C61A and C104A)
1mkk
homo-2-mer220-312
Assess
Structure of the Neuropilin-1/VEGF-A complex
4deq
homo-2-mer346-395
1×PO4;
Assess
HEPARIN-BINDING DOMAIN FROM VASCULAR ENDOTHELIAL GROWTH FACTOR, NMR, 20 STRUCTURES
1vgh
monomer346-395
Assess
HEPARIN-BINDING DOMAIN FROM VASCULAR ENDOTHELIAL GROWTH FACTOR, NMR, MINIMIZED AVERAGE STRUCTURE
2vgh
monomer346-395
Assess
Heparin-binding Domain from Vascular Endothelial Growth Factor
1kmx
monomer346-395
Assess

2 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
6t9d.1.Cmonomer0.76218-313
100.00
Assess
1kmx.1.Amonomer0.68344-394
96.15
Assess

27 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 15fv1.1.Cmonomer0.7640-134
100.00
Assess
Isoform 11kmx.1.Amonomer0.65181-231
96.15
Assess
Isoform 25fv1.1.Dmonomer0.7539-136
100.00
Assess
Isoform 24deq.1.Bmonomer0.64164-215
96.15
Assess
Isoform 35fv1.1.Dmonomer0.7539-136
100.00
Assess
Isoform 34deq.1.Bmonomer0.66158-209
96.15
Assess
Isoform 45fv1.1.Cmonomer0.7740-134
100.00
Assess
Isoform 44deq.1.Ahomo-2-mer0.58102-191
65.17
Assess
Isoform 55fv1.1.Dmonomer0.7839-136
100.00
Assess
Isoform 54deq.1.Bmonomer0.57102-173
56.34
Assess
Isoform 65fv2.1.Cmonomer0.7839-134
100.00
Assess
Isoform 85fv1.1.Dmonomer0.7739-136
100.00
Assess
Isoform 84deq.1.Bmonomer0.56102-185
62.65
Assess
Isoform 95fv1.1.Dmonomer0.8139-136
100.00
Assess
Isoform 105fv1.1.Dmonomer0.8139-136
97.27
Assess
Isoform 116t9d.1.Cmonomer0.76218-313
100.00
Assess
Isoform 114deq.1.Ahomo-2-mer0.62282-371
65.17
Assess
Isoform 125fv2.1.Cmonomer0.71219-314
100.00
Assess
Isoform 146t9d.1.Cmonomer0.74218-313
99.12
Assess
Isoform 141kmx.1.Amonomer0.66361-411
96.15
Assess
Isoform 156t9d.1.Cmonomer0.77218-313
100.00
Assess
Isoform 154deq.1.Bmonomer0.58282-365
62.65
Assess
Isoform 166t9d.1.Cmonomer0.73218-313
100.00
Assess
Isoform 161kmx.1.Amonomer0.69338-388
96.15
Assess
Isoform 176t9d.1.Cmonomer0.77218-313
100.00
Assess
Isoform 174deq.1.Bmonomer0.59282-353
56.34
Assess
Isoform 185fv2.1.Cmonomer0.67219-314
97.27
Assess